Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Xencor, Inc.
ISIN US98401F1057
|WKN A1W96L
Market cap (in EUR)
869 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 869 m |
| EPS, EUR | -1.61 |
| P/B ratio | 1.6 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 102 m |
| Net income, EUR | -215 m |
| Profit margin | -210.53% |
What ETF is Xencor, Inc. in?
There are 20 ETFs which contain Xencor, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Xencor, Inc. is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.01% | Equity United States Small Cap | 55 |
| UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc | 0.00% | Equity United States Multi-Factor Strategy | 9 |
| UBS MSCI USA Select Factor Mix UCITS ETF USD acc | 0.00% | Equity United States Multi-Factor Strategy | 94 |
| SPDR MSCI World Small Cap UCITS ETF | 0.01% | Equity World Small Cap | 1,436 |
| Xtrackers Portfolio UCITS ETF 1C | 0.00% | Equity World Multi-Asset Strategy | 681 |
| iShares S&P SmallCap 600 UCITS ETF | 0.07% | Equity United States Small Cap | 1,758 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.03% | Equity United States Small Cap | 1,875 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.01% | Equity United States Small Cap | 182 |
| UBS MSCI USA Select Factor Mix UCITS ETF USD dis | 0.00% | Equity United States Multi-Factor Strategy | 29 |
| UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc | 0.00% | Equity United States Multi-Factor Strategy | 31 |
| iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) | 0.00% | Equity United States Small Cap | 1,825 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.09% | Equity United States Health Care Biotech | 46 |
| iShares MSCI World Small Cap UCITS ETF | 0.01% | Equity World Small Cap | 6,377 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.09% | Equity United States Health Care Biotech | 750 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.01% | Equity United States Small Cap | 712 |
| SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist) | 0.01% | Equity World Small Cap | 25 |
| iShares MSCI World Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) | 0.00% | Equity World Small Cap | 193 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.04% | Equity United States Small Cap | 4,010 |
| Amundi S&P SmallCap 600 Screened UCITS ETF Dist | 0.08% | Equity United States Small Cap | 101 |
| L&G Pharma Breakthrough UCITS ETF | 3.61% | Equity World Health Care Innovation | 18 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.